Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts

Daiichi Sankyo Company

Market Cap: JP¥6.1t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

PeptiDream

Market Cap: JP¥203.9b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

GNI Group

Market Cap: JP¥134.6b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Nxera Pharma

Market Cap: JP¥88.0b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥70.9b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

Japan Tissue Engineering

Market Cap: JP¥20.9b

Engages in the regenerative medicine business in Japan.

StemRIM

Market Cap: JP¥18.6b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

Kidswell Bio

Market Cap: JP¥13.3b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

CellSource

Market Cap: JP¥11.2b

Engages in the regenerative medicine-related businesses in Japan.

Noile-Immune Biotech

Market Cap: JP¥7.9b

Researches and develops CAR-T cells for cancer immunotherapies.

TMS

Market Cap: JP¥7.1b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.